Topical Eugenol Successfully Treats Experimental <b><i>Candida albicans</i></b>-Induced Keratitis

Heba Ali Hassan, Mahmoud M. Geniady, Sayed F. Abdelwahab, Manal I. Abd-Elghany, Hatem A. Sarhan, Ahmed A. Abdelghany, Mohamed Kamel, Alejandra Rodriguez, Jorge L. Alió

Ophthalmic Research · 2018 · 18 citations · 22 references

Concepts

Abstract

<b><i>Purpose:</i></b> To<i></i> determine the efficacy of eugenol for the treatment of <i>Candida</i> keratitis in an experimental model. <b><i>Methods:</i></b> The in vitro<i></i> antifungal activity of eugenol and fluconazole was tested against <i>C. albicans</i> strains via the microbroth dilution method. An experimental model of <i>Candida albicans</i> keratitis was used. Rabbits were classified into those that received no treatment (control; group 1) and those that started eugenol treatment immediately (group 2) or after 4 days (group 3) of keratitis induction (<i>n</i> = 12–16 rabbits/group). The 2 treatment groups were assigned to 50 μL of 4 mg/mL eugenol drops hourly for 15 days, while the control group received saline. Corneal penetration of eugenol was measured using HPLC, and corneal toxicity was evaluated clinically and histopathologically. <b><i>Results:</i></b> The in vitro<i></i> minimum inhibitory concentrations of eugenol and fluconazole against <i>C. albicans</i> were 2 and > 0.4 mg/mL, respectively. A 4-mg/mL preparation of eugenol in propylene glycol was the maximum nontoxic dose on rabbit corneas as suggested by clinical and histopathologic findings. At least 75% of all eugenol-treated eyes recovered from keratitis, with improvement in the remaining 25% of the eyes compared to controls. <b><i>Conclusions:</i></b> Eugenol can act as a natural, safe, and effective treatment for fungal keratitis, regardless of whether treatment is started immediately or after 4 days of keratitis induction.

References

22